Related Experiment Video
Updated: Aug 7, 2026

Rapid Homogeneous Detection of Biological Assays Using Magnetic Modulation Biosensing System
Published on: June 13, 2010
A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis
Turgut Aytur1, Jonathan Foley, Mekhail Anwar
1Department of Electrical Engineering and Computer Sciences, University of California at Berkeley, CA 94720-3200, USA.
A novel biosensor using magnetic beads replaces traditional labels in immunoassays for point-of-care diagnostics. This complementary metal oxide semiconductor (CMOS) technology enables rapid, low-cost disease detection with high accuracy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunodiagnostics
Background:
- Current laboratory tests often lack the speed and portability required for point-of-care (POC) settings.
- Enzymatic labels in traditional immunoassays like ELISA can be complex and costly.
- There is a significant need for advanced diagnostic technologies for rapid disease detection at the POC.
Purpose of the Study:
- To develop and validate a novel biosensor for detecting micron-scale paramagnetic beads as a replacement for enzymatic labels.
- To leverage complementary metal oxide semiconductor (CMOS) technology for integrated, low-cost diagnostic systems.
- To demonstrate the efficacy of the biosensor in quantifying magnetic beads via immunological recognition for clinical applications.
Main Methods:
- Fabrication of a novel biosensor using standard CMOS manufacturing processes.
- Quantification of magnetic beads bound to the sensor surface through specific antibody-antigen interactions.
- Validation of the biosensor using purified mouse IgG and human anti-dengue virus IgG in clinical serum samples.
- Demonstration of magnetic field application for controlled removal of non-specifically bound beads.
Main Results:
- The biosensor demonstrated sensitivity comparable to ELISA for purified protein detection.
- A high correlation was observed between ELISA optical density and biosensor output in clinical assays.
- Effective removal of non-specifically bound magnetic beads was achieved using a controlled magnetic field, simplifying the washing step.
- The sensor platform shows potential for mass production at a low cost.
Conclusions:
- The developed CMOS biosensor offers a promising alternative to conventional ELISA labels using magnetic beads.
- This technology facilitates the development of inexpensive, compact, and sophisticated diagnostic systems for various diseases.
- The biosensor platform is suitable for simplified, rapid, and accurate point-of-care diagnostic tests.
More Related Videos
09:58Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
Published on: June 23, 2022
08:22Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
Published on: February 23, 2020
Related Concept Videos
Microbial Biosensors
Automated Microbial Diagnostics